To examine if PLXNA1 mutation status might aid to guide molecular therapy decisions, a panel of primary pancreas cancer cell lines with known PLXNA1 mutation status including SB.06 (PLXNA1 c.2587G>A), SB.07, Panc01.28. This evidence concerns the gene PLXNA1 and pancreatic neoplasm.